Craig Beeson to Immunotherapy, Adoptive
This is a "connection" page, showing publications Craig Beeson has written about Immunotherapy, Adoptive.
Connection Strength
0.249
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
Score: 0.142
-
Promoting thiol expression increases the durability of antitumor T-cell functions. Cancer Res. 2014 Nov 01; 74(21):6036-6047.
Score: 0.107